The management of biotechnology data has become a central focus for Saudi Arabia as the country accelerates its specialized scientific programs. Alrebdi Fahad Alrebdi, President of the National Data Management Office at the Saudi Data & AI Authority (SDAIA), detailed this direction during the fourth Riyadh Global Medical Biotechnology Summit. The event took place in the presence of Prince Abdullah bin Bandar bin Abdulaziz, Minister of National Guard, alongside several international ministers and officials.
National Strategic Goals for Biotechnology
Saudi leadership provides direct support to the sector to improve human health and assist national economic diversification. Under the National Biotechnology Strategy, the Kingdom plans to establish itself as a primary biotechnology center in the Middle East by 2030. The long-term target seeks to transform the country into an international hub by 2040.
Managing Biotechnology Data for Healthcare
Modern medical research depends heavily on large-scale computational systems and structured records. Alrebdi stated that medical developments in genomics, precision medicine, drug discovery, and early diagnostic procedures rely directly on digital information. Consequently, modern biotechnology data must be governed, shared, and stored within secure and responsible frameworks to protect user privacy while advancing health technology.
“Advances in genomics, precision medicine, drug discovery and early diagnosis increasingly rely on data. This requires data to be managed, governed and shared in a trusted, secure and responsible manner.”
Alrebdi Fahad Alrebdi, President of the National Data Management Office at SDAIA
Integration with the National Data Lake
SDAIA has already executed large-scale infrastructure projects to consolidate institutional information across government departments. The authority integrated more than 500 government systems from approximately 90 official entities into the National Data Lake. In addition, the organization published more than 23,000 open datasets gathered from over 340 public and private sector contributors to support the digital economy.
Collaborative Opportunities for Medical Innovation
The summit provides a platform to connect medical scientists, laboratory researchers, policymakers, and private investors. Officials noted that cross-sector cooperation will accelerate practical applications for clinical care. These structured partnerships aim to generate durable medical solutions that directly enhance patient treatment outcomes and broader public health quality.
Source: Saudi Press Agency
